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Crude extracts of Solanum lyratum protect
endothelial cells against oxidized low-density
lipoprotein-induced injury by direct antioxidant
action
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Background: Oxidized low-density lipoprotein (oxLDL) is a proatherogenic molecule that accumulates in the vascular
wall and contributes to the pathogenesis of vascular dysfunction early in the development of atherosclerosis. The whole
plant of Solanum lyratum is a traditional Chinese medicine that has been used for centuries to treat cancer, tumors, and
herpes. However, the cellular and molecular mechanisms of its antioxidant effects are still largely unknown. This study
tested the hypothesis that Solanum lyratum Thunberg extract (SLE) could block oxLDL-induced endothelial dysfunction
in cultured human umbilical vein endothelial cells (HUVECs). Possible mechanisms were explored.
Methods: Antioxidative activities of SLE were assayed by measuring the scavenging of 1,1-diphenyl-2-picryl-hydrazyl
(DPPH) free radical and the inhibition of copper-mediated or cell-mediated LDL oxidation. Production of reactive
oxygen species (ROS) and the expression of adhesion molecules were evaluated in HUVECs after exposure to oxLDL and
treatment with SLE. Several apoptotic signaling pathways were investigated.
Results: SLE scavenged DPPH and also delayed the kinetics of LDL oxidation in a dose-dependent manner. SLE
attenuated the level of oxLDL-induced ROS generation, diminished the expression of endothelial NO synthase (eNOS),
and enhanced the expression of adhesion molecules (vascular cellular adhesion molecule-1, E-selectin, and monocyte
chemotactic protein-1) and the adherence of monocytic THP-1 cells to HUVECs. OxLDL increased the concentration of
intracellular calcium, disturbed the balance of the Bcl-2 protein family, destabilized the mitochondrial membrane
potential, increased the amount of cytochrome c released into the cytosol, and increased the activation of caspase 3. These
detrimental effects were ameliorated dose-dependently by SLE (P < .05).
Conclusion: Crude extracts of Solanum lyratum protect against oxLDL-induced injury in endothelial cells by direct
antioxidant action. (J Vasc Surg 2009;50:849-60.)
Clinical Relevance: Atherosclerosis is a chronic inflammatory disease characterized by lipid-laden lesions within arterial
blood vessel walls. Inhibiting the oxidation of low-density lipoprotein may be an effective way to prevent or delay the
progression of atherosclerosis. This study underscores the potential clinical benefits and application of Solanum lyratum
extract in controlling oxidized low-density lipoprotein-associated vascular injury and cardiovascular disease.Atherosclerosis is considered to be a chronic inflamma-
tory disease. Oxidized low-density lipoprotein (oxLDL) is
an important biomolecule that triggers and sustains athero-
sclerotic lesions. An initial event in atherosclerosis is the
oxidation of LDL by free radicals, transition metals, and
lipoxygenases, which involves cleavage of polyunsaturated
fatty acids within the LDL particle. Oxidation of LDL can
be achieved in vitro by incubation with copper ions or in a
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the subintimal space by a complex mechanism character-
ized by the enhanced expression of chemoattractant inter-
leukins, adhesion molecules, and various cell-membrane
cytokine-receptors. Previous study demonstrated that
oxLDL-induced reactive oxygen species (ROS) generation
was an upstream signal.1 A progressive rise of cellular ROS
subsequently leads to an activation of apoptotic signaling,2
which includes reduction of the mitochondrial transmem-
brane potential with concomitant release of the mitochon-
drial protein cytochrome c and subsequent activation of
caspase-3.3 The inhibition of LDL oxidation and oxLDL-
induced ROS generation may prevent or delay the progres-
sion of atherosclerosis.
An Eastern crude drug, Solanum lyratum, has been
used to treat cancers, tumors, and warts for centuries, and it
corresponds to the European crude anticancer drug Sola-
num dulcamara.4 The whole plant of Solanum lyratum has
extensive clinical applications. The chemical constituents of
Solanum lyratumwere isolated and identified as aspidistrin,
methylproto-aspidistrin, furostanol glycosides, and steroi-
dal glycosides.5-8
Many biologic actions of the extract of Solanum lyratum
Thunberg (SLE) have been previously reported. For example,
SLE inhibits anaphylactic reaction9 andmodulates nitric oxide
(NO) production by inhibiting protein kinase C activity.10
SLE is also commonly used as an anticancer drug to treat
cancers of the liver, lung, and esophagus.11,12
Studies on the anticancermechanisms of SLE have shown
that SLE induces HeLa cell apoptosis by up-regulating ex-
pression of Fas/FasL,12 low expression of Bcl-2, and up-
regulation of Bax,13 promoting the formation of cyclic aden-
osine monophosphate (cAMP) and activating protein kinase
A (PKA) in gastric cancer cells.14 Kang et al15 demonstrated
that Solanum lyratum Thunberg exhibited hepatoprotective
activity by preserving the glutathione content and the activity
of superoxide dismutase (SOD) and by reducing the produc-
tion of malondialdehyde (MDA), an end product of lipid
peroxidation in hepatic tissue.
From this research, we hypothesized that SLE could
protect against oxLDL-induced endothelial dysfunction by
down-regulation of ROS generation. We undertook the
current study to explore whether SLE could scavenge free
radicals and prevent oxidative modification of LDL. We
also evaluated the effects of SLE on oxLDL-induced ROS
generation and determined other downstream events, in-
cluding the levels of endothelial NO synthase (eNOS)
expression, adherence of monocytic THP-1 cells to human
umbilical vein endothelial cells (HUVECs), and adhesion
molecules expression. Furthermore, several ROS-mediated
apoptotic signalings, such as the accumulation of intracel-
lular calcium and mitochondrial destabilization, and the
activation of caspase-3 were also investigated.
METHODS
Plant material and preparation of crude extracts of
Solanum lyratum. Solanum lyratum was cell grown and
planted in the medicinal herb garden of China MedicalUniversity. The whole plant of Solanum lyratum (600 g)
was extracted repeatedly with 50% ethanol at room temper-
ature. The combined ethanol extracts were filtered and
evaporated under reduced pressure to yield a brownish
viscous residue (58.44 g). For the present experiments,
the crude extracts were dissolved in dimethyl sulfoxide
(DMSO).
Cell cultures. HUVECs were isolated with collage-
nase and used at passage 2 to 3 as previously described.16
After dissociation, the cells were collected and cultured on
gelatin-coated culture dishes in medium 199 with low
serum growth supplement, penicillin (100 IU/mL), and
streptomycin (0.1 mg/mL). Subcultures were performed
with trypsin-ethylenediaminetetraacetic acid (EDTA). Me-
dia were refreshed every 2 days. THP-1, a human mono-
cytic leukemia cell line, was obtained from ATCC (Rock-
ville, Md) and cultured in Roswell Park Memorial Institute
(RPMI) media with 10% fetal bovine serum at a density of
2 to 5  106 cells/mL, as suggested by the vendor’s
product specification sheet.
Free radical scavenging activity of 1,1-diphenyl-
2-picryl-hydrazyl. The radical scavenging capacity of SLE
was determined by the 1,1-diphenyl-2-picryl-hydrazyl
(DPPH•) scavenging method. This spectrophotometric
assay uses the stable radical DPPH• as a reagent.17 The
capability to scavenge the DPPH• radical was calculated
using the following equation: DPPH• scavenging effect
(%) [1 (AS/AC )] 100, whereAC is the absorbance
of the control (0.5 mL of 0.1mM ethanol solution of
DPPH without SLE), and AS is the absorbance in the
presence of SLE.
Lipoprotein and oxLDL preparation. Native LDL
was isolated and oxidatively modified from fresh normolipi-
demic human serum by sequential ultracentrifugations, as
previously described.16 The EDTA-free LDL was immedi-
ately used for the measurement of the kinetics of LDL
oxidation by continuously monitoring the change in the
absorbency of conjugated diene at 232 nm at 37°C for up
to 6 hours. In some experiments, LDL oxidation was
estimated by measuring the production of thiobarbituric
acid reactive substances (TBARS), as described previously.18
MDA, an end product of lipid peroxidation, was used as a
standard.
Measurement of LDL oxidation in HUVECs.
Once HUVECs had reached confluence in 24-well plates,
culture medium was removed and the cells were washed
twice with M199 medium. The cells were then incubated
with native LDL (100 g/mL) in phenol red free medium
in the presence of various concentrations of SLE for 24
hours. At the end of the incubation, media were collected
and the levels of TBARS were measured as an index of LDL
oxidation.
Measurement of ROS production. ROS have been
implicated in the pathophysiology of many vascular disor-
ders. The effect of SLE on ROS production in HUVECs
was determined by a fluorometric assay using 2,= 7=-
dichlorofluorescein acetoxymethyl (DCF-AM) ester (Mo-
lecular Probes, Eugene, Ore). Confluent HUVECs (104
ntrol
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concentrations of SLE for 2 hours. OxLDLwas then added
to the media in the absence or presence of SLE for 2 hours.
After the removal of media from wells, cells were incubated
with 10M DCF-AM for 1 hour.
The fluorescence intensity was measured with a flu-
orescence microplate reader (Labsystem, Ramsey, Minn)
calibrated for excitation at 485 nm and emission at 538
nm. The percentage of increase in fluorescence per well
was calculated by the formula [(Ft2  Ft0)/Ft0]  100,
where Ft2 is the fluorescence at 2 hours of oxLDL
exposure and Ft0 is the fluorescence at 0 minutes of
oxLDL exposure.
Immunoblotting. To determine whether SLE could
ameliorate the oxLDL-induced apoptosis-regulating pro-
teins, HUVECs were grown to confluence, pretreated with
SLE for 2 hours, and then stimulated with oxLDL for 24
hours. After treatment, cytosolic andmitochondrial protein
fractions of cells were extracted as previously described.16
Protein was measured by the Bradford method.19 Cyto-
solic SOD-1, SOD-2, eNOS, and cytochrome c, as well
as mitochondrial Bax and Bcl-2 expressions, were deter-
Fig 1. Antioxidative activities of Solanum lyratum ex
radical scavenging activity of SLE was determined by inc
a total volume of 1mL ethanol for 30minutes.A,Chang
on Cu2-induced oxidation of low-density lipoprotein w
of diene formation and (C) level of reduction in thiobar
incubation for 16 hours. D, The effect of SLE on reduct
incubation with human umbilical vein endothelial cells f
three independent analyses. *P  .05 compared with comined by sodium dodecyl sulfate polyacrylamide gelelectrophoresis (SDS-PAGE) and immunoblot assay.
The blots were incubated with primary antibodies (1:
1000) overnight at 4°C, followed by incubation with
horseradish peroxidase-conjugated secondary antibody (1:
5000) for 1 hour. To control equal loading of total protein in
all lanes, blots were stained with mouse anti--actin antibody
at a dilution of 1:50000. The bound immunoproteins were
detected by an ECL kit (Amersham, Berkshire, UK). The
intensities were quantified by densitometric analysis (Digital
Protein DNA Imagineware, Huntington Station, NY).
Adhesion assay. Vascular inflammation is caused by
the increase in leukocyte-endothelium adhesion by an up-
regulation of endothelial cell adhesion molecules. To de-
termine whether SLE could reduce the oxLDL-induced
adherence of monocytic cells and endothelial cells,
HUVECs (1  105 cells/mL) were cultured in 96-well
flat-bottom plates (0.1 mL/well) for 1 to 2 days. Cells were
pretreated with 10 g/mL of SLE for 2 hours, followed by
oxLDL (130 g/mL) for 24 hours. The media was then
removed, and 0.1 mL/well of THP-1 cells (prelabeled
with BCECF-AM 4 M for 30 minutes in RPMI at 1 
106 cells/mL density) were added in RPMI. The cells
(SLE). The 1-diphenyl-2-picryl-hydrazyl (DPPH) free
ng various concentrations of SLE with 1 mM DPPH in
e absorbance at 517 nmwas recorded. The effect of SLE
termined by measuring (B) the prolongation of lag time
ic acid reactive substances (TBARS) concentration after
TBARS concentration of low-density lipoprotein after
hours. Data are shown as the mean  standard error of
.tract
ubati
e in th
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ion in
or 24were allowed to adhere at 37°C for 1 hour in a 5% carbon
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by gentle aspiration.
Plates were washed three times with M199. The num-
ber of adherent cells was estimated by microscopic exami-
nation, and then lysed with 0.1 mL 0.25% Triton X-100.
The fluorescence intensity was measured with a fluores-
cence microplate reader (Labsystem) calibrated for an ex-
citation at 485 nm and for emission at 538 nm.
Adhesion molecule expression. To determine whether
SLE could attenuate the level of adhesion molecule expres-
sion induced by oxLDL, HUVECs were grown to conflu-
ence, pretreated with SLE (10 g/mL) for 2 hours, and
stimulated with oxLDL (130 g/mL) for 24 hours. The
HUVECs were harvested and incubated with fluorescein
isothiocyanate (FITC)-conjugated anti-vascular cell adhe-
sion molecule-1 (VCAM-1), anti-E-selectin, and anti-
monocyte chemotactic protein-1 (MCP-1; R&D, Minne-
apolis, Minn) for 45 minutes at room temperature. After
the HUVECs had been washed three times, their immuno-
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Fig 2. Inhibitory effects of Solanum lyratum extract (
reactive oxygen species (ROS) production in human um
for 2 hours with the indicated concentration of SLE (2.5
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increased intensity. C and D, Representative Western
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oxLDL-stimulated HUVECs.fluorescence intensity was analyzed by flow cytometry usinga FACScan flow cytometer (Becton Dickinson, Mountain
View, Calif).
Measurement of [Ca2]i. Intracellular calcium rise
is involved in oxLDL-induced endothelial apoptosis.20
Therefore, the effects of SLE on the increase in oxLDL-
induced intracellular calcium concentration [Ca2]i were
determined. HUVECs were seeded onto 24-mm glass cov-
erslips, pretreated with SLE for 2 hours, and then stimu-
lated with oxLDL (130 g/mL) for the indicated time
periods. The cells on the coverslips were loaded with 2 M
fura-2 AM (Molecular Probe) in M199 and allowed to
stand for 30 minutes at 37°C. The fluorescence of the cells
on each coverslip was measured and recorded using an
inverted Olympus IX-70 microscope (Olympus, Tokyo,
Japan). The concentration of [Ca2]i in endothelial cells
was monitored with a Delta Scan System (Photon Technol-
ogy International, Princeton, NJ) at an emission wave-
length of 510 nm, with excitation wavelengths alternating
between 340 and 380 nm, and calculated using Grynk-
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The lipophilic cationic probe fluorochrome 5,58,6,68-
tetraethylbenzimidazolcarbocyanine iodide (JC-1) was
used to explore the effects of SLE on mitochondria mem-
brane potential (	
m). JC-1 exhibits potential-dependent
accumulation in mitochondria, as indicated by the fluores-
cence emission shift from 530 to 590 nm. After cells were
treated with oxLDL (130 g/mL) for 24 hours in the
presence or absence of various concentrations of SLE, cells
(5 104 cells/24-well plates) were rinsed with M199, and
JC-1 (5 M) was loaded. Cells were incubated 20 minutes
at 37°C and examined under a fluorescence microscope.
Determination of the 	
mwas done using a FACScan flow
cytometer.22
Measurement of active caspase-3. To explore the
effects of SLE on oxLDL-induced caspase-3 activation,
HUVECs were pretreated with SLE for 2 hours and then
stimulated with oxLDL (130 g/mL) for 24 hours. The
level of active caspase-3 was detected by flow cytometry
using a commercial fluorescein active caspase kit (BioVision,
Mountain View, Calif) under a fluorescence microscope.
The activity of caspase-3 was also measured by an EnzChek
caspase-3 assay kit according to the manufacturer’s instruc-
tions (Molecular Probes Inc). The fluorescence generated
from cleavage of the substrate by caspase-3 was monitored
with a fluorescence microplate reader (Labsystem) cali-
brated for excitation at 496 nm and for emission at 520 nm.
Determination of apoptosis. To determine the effect
of SLE on oxLDL-induced cytotoxicity, HUVECs were
first incubated with SLE for 2 hours and then stimulated
with oxidized LDL for 24 hours. Apoptotic cells were
assessed by a terminal deoxynucleotide transferase-mediated
deoxy uridine triphosphate nick-end labeling (TUNEL)
assay under a fluorescence microscope or in a flow cytom-
eter.
Statistical analyses. All experiments were repeated
three or more times, and one of these results is provided.
Results are expressed as mean standard error. Differences
between the groups were analyzed using one-way analysis
of variance, followed by t test. A value of P  .05 was
considered statistically significant.
RESULTS
DPPH radical scavenging and oxidation of LDL.
An SLE concentration of 0.11 mg/mL was required for
scavenging 50% of the DPPH radicals (Fig 1, A). The
copper-induced oxidation of LDL in the presence of vari-
ous concentrations of SLEwas determined by following the
kinetics of conjugated diene formation and MDA forma-
tion. In the presence of various concentrations of SLE (2.5
to 20 g/mL), the sigmoidal curves of diene formation
shifted to the right, indicating that the oxidation of LDL
was delayed (Fig 1, B). The effective concentrations of SLE
that inhibit copper-induced LDL oxidation were sub-
sequently studied by measuring the concentrations of
TBARS. Incubation of LDL with copper for 16 hours
resulted in significantly increased levels of MDA (1.3 
0.7 nM/mg for native LDL and 18.4  1.1 nM/mg forcopper-treated LDL; Fig 1, C). MDA levels in the SLE-
treated groups were decreased in a dose-dependent man-
ner. SLE at the dose of 20 g/mL significantly reduced the
MDA level to 4.7  0.8 nM/mg protein (Fig 1, C). As
expected, the inhibitory effect of SLE on endothelial cell-
mediated LDL oxidation was very similar (Fig 1,D). These
results indicate that SLE is a potent antioxidant.
ROS generation. A previous study demonstrated that
oxLDL evokes a progressive rise in cellular ROS, which
subsequently leads to the activation of apoptotic signal-
ing.23 We, therefore, investigated the effects of SLE on
the generation of ROS, a potential factor related to
oxLDL-induced endothelial cell injury, by using 2,= 7=-
dichlorofluorescein diacetate as a fluorescence probe. Pre-
treatment of HUVECs with SLE (2.5 to 20 g/mL) for 2
hours before exposure to oxLDL (130 g/mL) signifi-
cantly decreased the level of ROS generation in a dose-
dependent manner (all P  .05; Fig 2, A, B). Intracellular
ROS levels are regulated by the balance between ROS
generation and antioxidant enzymes. ROS are able to
inactivate antioxidative enzymes, leading to oxidative
stress.
We next turned our attention to the expression of SOD
isoforms in endothelial cells in response to oxLDL. Our
results showed that SOD-1, but not SOD-2, expression
was diminished after treatment with oxLDL for 24 hours;
however, SOD-1 was expressed normally after pretreat-
Fig 3. Effects of Solanum lyratum extract (SLE) on oxidized
low-density lipoprotein (oxLDL)-impaired endothelial nitric oxide
synthase (eNOS) protein expression. Human umbilical vein endo-
thelial cells (HUVECs) were pretreated for 2 hours with the
indicated concentrations of SLE, followed by oxLDL for 24 hours.
For Western blot analyses, a monoclonal anti-eNOS and a mono-
clonal anti--actin antibody (for normalization) were used. The
values represent means  standard error from three separate ex-
periments. *P  .05 vs oxLDL treatment.ment with SLE (Fig 2, C, D).
om th
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October 2009854 Kuo et alExpresion of eNOS protein. NO is produced in en-
dothelial cells by the constitutively expressed enzyme
eNOS. Considerable evidence indicates that oxLDL-
Fig 4. Effect of Solanum lyratum extract (SLE) on oxid
human umbilical vein endothelial cells (HUVECs) to T
Representative fields of monocytes adhering to HUVECs w
data for monocyte adherence to endothelial cells incubate
indicated concentrations of SLE for 2 hours, followed by tre
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cytometry. The values represent means standard error frcaused endothelial dysfunction is associated with dimin-ished expression of eNOS. We examined eNOS protein
expression after treatment with oxLDL. Expression of
eNOS proteins was significantly reduced in HUVECs after
ow-density lipoprotein (oxLDL)-induced adhesiveness of
monocytic cells and adhesion molecule expression. A,
epresentative treatments as indicated. B,Quantification of
h oxLDL (130 g/mL) for 24 hours or pretreated with
nt with oxLDL.C,HUVECswere incubated with oxLDL
r 24 hours. Histogram of cell surface expression of vascular
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cells treated with SLE (10 g/mL) before oxLDL was
almost that of the control level.
Adherence of THP-1 cells to HUVECs and adhe-
sion molecule expression. OxLDL damages endothelial
cells by inducing the expression of adhesion molecules,
which subsequently leads to the tethering, activation, and
attachment of monocytes to the endothelial cells.24 To test
the effect of SLE on monocyte adhesion to HUVECs,
confluent monolayers of HUVECs were pretreated with
various concentrations of SLE for 2 hours and then stimu-
lated with oxLDL (130 g/mL) for 24 hours, followed by
incubation with THP-1 cells for 1 hour at 37°C. As shown
in Fig 4 (A and B), oxLDL stimulated the adhesion of
THP-1 cells to HUVECs; however, SLE treatment inhib-
ited this adhesion in a dose-dependent manner (2.5 to 20
g/mL; all P  .05). The effect of SLE on the surface
expression of adhesion molecules on HUVECs exposed to
oxLDL was subsequently examined. Treatment with ox-
LDL (130 g/mL) for 24 hours significantly increased
VCAM-1, E-selectin, andMCP-1 expression (Fig 4,C). Flow
cytometry revealed that the induction of adhesion molecule
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Fig 5. Effect of Solanum lyratum extract (SLE) on cy
lipoprotein (oxLDL) in fura 2-loaded human umbilical
Materials and Methods. Calcium changes are color cod
levels. The values represent means standard error of2
vs oxLDL treatment.expression was attenuated by 10 g/mL SLE (all P .05).Intracellular calcium accumulation. To investigate
the effect of chronic exposure of endothelial cells to a
cytotoxic concentration of oxLDL on intracellular calcium,
we incubated HUVECs with oxLDL (130 g/mL) in the
absence or presence of SLE. The basal [Ca2]i concentra-
tion increased from 50  3nM to 203  4nM in oxLDL-
treated cells. SLE significantly inhibited the oxLDL-
enhanced rise in intracellular calcium (all P .05; Fig 5).
Mitochondrial transmembrane permeability tran-
sition. To examine whether inhibition of mitochondrial
disruption accounts for the antiapoptotic effect of SLE, we
tested the effects of oxLDL onmitochondrial permeability.
When HUVECs were exposed to oxLDL (130 g/mL),
the 	
mwas depolarized, as shown by the increase in green
fluorescence (Fig 6, A, middle panel). Pretreatment with
SLE reduced the change in 	
m, as indicated by repression
of green fluorescence and restoration of red fluorescence
(Fig. 6A, right panel). The results from flow cytometry
supported these findings. As seen in Fig 6 (B) oxLDL
caused a marked increase in JC1 green fluorescence (mid-
dle) compared with the control (left). Pretreatment with
SLE caused marked inhibition of this apoptotic index
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chondrial membrane potential. Because oxLDL depolar-
ized the membrane potential and SLE maintained it, we
investigated whether SLE also influenced the equilibrium
of Bcl-2 family proteins. Immunoblotting studies demon-
strated that oxLDL down-regulated the antiapoptotic
(Bcl-2) and up-regulated the proapoptotic (Bax) proteins,
whereas SLE pretreatment effectively repressed these ox-
LDL-evoked proapoptotic events (Fig 6, C). Quantitative
analysis showed that oxLDL significantly decreased the
Bcl-2 to Bax ratio, and that SLE pretreatment preserved
this antiapoptotic index (Fig 6, C bar graphs).
Disruption of mitochondrial membrane function is
known to result in the specific release of the mitochondrial
enzyme cytochrome c into the cytosol. Therefore, mito-
chondria were separated from the cytosolic fraction and
detected by Western blot. The amount of cytochrome c
released into the cytosolic fraction was much greater in
HUVECs that had been incubated with oxLDL for 24
hours than in control cells (Fig 6, C). The results indicate
that SLE significantly prevented oxLDL-induced release of
cytochrome c (Fig 6, D).
Activation of caspase-3. Caspase-3 is a key factor in
(A)      control               oxLDL            oxLDL+SLE               (C)                 
(B)
cytosolic 
cytochrome c 
β-actin 
Bcl-2 
Bax 
β-actin 
Fig 6. Effect of Solanum lyratum extract (SLE) on mi
was assessed with the signal from monomeric and J-a
Methods: no treatment (left); oxidized low-density lipop
fluorescence was confirmed with flow cytometry. C an
mitochondrial cytochrome c release in response to oxL
incubated with oxLDL (130 g/mL) in the absence or p
for 24 hours.C,RepresentativeWestern blots and (D) su
and down-regulated antiapoptotic (Bcl-2) proteins (top)
fraction (bottom). Pretreatment with SLE suppressed the
densitometric analysis; the values are presented as means
oxLDL treatment.the execution of mitochondrial apoptosis.20 To examinewhether oxLDL and SLE ultimately influence this factor in
modulating apoptosis, we determined the active form of
caspase-3 by using fluorescence microscopy and flow cy-
tometry. Active caspase-3 was significantly increased in cells
that had been treated with oxLDL for 24 hours (Fig 7, A
and B). In contrast, the activation of caspase-3 by oxLDL
was suppressed in cells that had been pretreated with 10
g/mL SLE. The activity of caspase-3 was confirmed by
using the EnzCaspase-3 assay kit. The results showed that
oxLDL significantly upregulated caspase-3 activity by 3.1-
fold, whereas SLE pretreatment effectively suppressed the
activity of this apoptotic factor, implying a stimulatory
effect of oxLDL and inhibitory action of SLE on caspase-3
activity (Fig 7, C, all P  .05).
Apoptosis ofHUVECs. To further ascertain whether
cell death induced by oxLDL was an apoptotic event in
HUVECs, oxLDL-treated cells were analyzed biochemi-
cally using TUNEL and 4=,6-diamidino-2-phenylindole
staining assays and evaluated by microscopic observation
and flow cytometry. Cells incubated with oxLDL for 24
hours showed typical features of apoptosis, including the
formation of condensed nuclei (Fig 8). These features were
not observed in the SLE-pretreated HUVECs. The results
                                              (D) 
    oxLDL 
SLE (µg/mL) 
2.5      5    10    20 
Ex
pr
es
si
on
 ra
tio
 (B
cl
-2
/B
ax
)
0.0
0.5
1.0
1.5
2.0
2.5
*
*
*
*
oxLDL (130 µg/mL)          -           +          +         +           +          +
SLE (µg/mL)                    0           0         2.5        5         10         20
   
   
   
   
E
xp
re
ss
io
n 
ra
tio
(C
yt
os
ol
ic
 c
yt
oc
hr
om
e 
c/
β -
ac
tin
) 
0
50
100
150
200
250
300
*
* *
oxLDL (130 µg/mL)     -              +             +              +             +            +
SLE (µg/mL)                0             0            2.5            5            10          20
ndrial transmembrane permeability transition. A, 	
m
ate JC-1 fluorescence, as described in Materials and
(oxLDL; middle); and oxLDL plus SLE (right).B, JC-1
Immunoblotting analysis of Bcl-2 protein family and
nd SLE. Human umbilical vein endothelial cells were
ce of indicated concentrations (2.5-20 g/mL) of SLE
y data showing oxLDL up-regulated proapoptotic (Bax)
ncreased concentration of cytochrome c in the cytosolic
optosis-provoking alterations. Results were subjected to
andard error of three separate experiments. *P  .05 vs          
          
tocho
ggreg
rotein
d D,
DL a
resen
mmar
and i
se ap
 stof the cell viability assay and the phenotypic features of
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 4 Kuo et al 857apoptosis suggest that SLE is a potent inhibitor of the
oxLDL-induced cytotoxicity in cultured HUVECs.
DISCUSSION
The oxidant stress imposed by oxLDL appears to acti-
oxLDL (130 µg/mL)          -       
SLE (10 µg/mL)                -      
A
ct
iv
e 
C
as
pa
se
 3
 (p
os
iti
ve
 c
el
ls
 ; 
%
)
0
5
10
15
20
25
30
35
A
ct
iv
ity
 o
f c
as
pa
se
-3
 
(p
 m
ol
e/
m
g 
pr
ot
ei
n)
0
2
4
6
8
10
12
oxLDL (130 µg/mL)     -        
SLE (µg/mL)                0       
control                             o(A) 
(B) 
(C) 
Fig 7. Effects of Solanum lyratum extract (SLE) on o
activation. Human umbilical vein endothelial cells (HUV
of indicated concentrations of SLE for 24 hours. A, Flu
cells (left), human umbilical vein endothelial cells (HUV
SLE (right). B, Fluorescence intensity of cells was mea
3.1-fold higher in oxLDL-treated HUVECs than in the c
pretreated with SLE (2.5 to 20 g/mL). Data are exp
analyses. *P  .05 vs oxLDL treatment.vate the signaling pathways leading to apoptosis of endo-thelial cells. ROS generation is the earliest apoptotic signal
of the addition of oxLDL,1 and then multiple downstream
events are activated by secondary messengers.25 Antioxi-
dants that reduced ROS level inhibited apoptosis, and
those that did not reduce ROS level were ineffective.26 The
  +                 +       
  -                 +  
*
*
*
* *
            +             +             +             +
           2.5            5           10           20 
L                         oxLDL +SLE 
ed low-density lipoprotein (oxLDL)-induced caspase-3
were incubated with oxLDL in the absence or presence
ent images show the activated caspase-3 level in control
stimulated with oxLDL (middle), and in the presence of
with flow cytometry. C, The activity of caspase-3 was
l but was limited to a 2.6-fold to 0.9-fold increase when
d as the mean  standard error of three independent        
         
     + 
      0
xLD
xidiz
ECs)
oresc
ECs)
sured
ontro
resseaim of the present study was to test the hypothesis that SLE
s oxL
JOURNAL OF VASCULAR SURGERY
October 2009858 Kuo et alcould protect against oxLDL-induced endothelial dysfunc-
tion. Our results revealed that SLE effectively scavenged
DPPH radicals and inhibited both copper- and HUVEC-
mediated LDL oxidation. Indeed, oxLDL-induced ROS
generation was attenuated in the presence of SLE. The
reduction in the generation of ROS is likely due to the
direct scavenging effect of SLE. This effect subsequently
increased the bioavailability of NO, reduced the inflamma-
tory response, maintained the endothelial [Ca2]i level,
and stabilized the mitochondrial membrane potential,
thereby preventing the release of cytochrome c, a molecule
required for the activation of caspase-3 that executes the
cell death program. These findings indicate that SLE pro-
tects against oxLDL-induced damage by direct antioxida-
control                                 ox
D
N
A 
fra
gm
en
ta
tio
n 
(p
os
iti
ve
 c
el
ls
; %
) 
0
10
20
30
40
50
control    
Fig 8. Effect of Solanum lyratum extract (SLE) on oxidi
apoptosis. Human umbilical vein endothelial cells were i
and presence (right) of 10 g/mL SLE for 24 hours.To
Cells stained using terminal deoxynucleotide transfera
(TUNEL) assay. Fluorescence intensity of cells was mea
standard error of three independent analyses. *P  .05 vtive action.ROS generated in endothelial cells include superoxide
(·O2), hydrogen peroxide (H2O2), peroxynitrite (·ONOO),
NO, and hydroxyl (·OH) radicals. Intracellular ROS levels
are regulated by the balance between ROS-generating en-
zymes and antioxidant enzymes that include SOD, catalase,
and glutathioneperoxidase. SODsprotect against superoxide-
mediated cytotoxicity by catalyzing .O2 to form H2O2;
however, SOD-1, but not SOD-2, is inactivated by H2O2
formed by dismutation of the superoxide anion.27 An in-
crease in activity of SOD-1 prevents oxLDL-induced endo-
thelial dysfunction.28 Our results showed that the effects of
SLE on the reduction of ROS preceded the preservation of
SOD-1 (2 vs 24 hours), suggesting that the protective
effects of SLE against oxLDL-induced endothelial dysfunc-
                           oxLDL+SLE 
*
xLDL      oxLD+SLE
w-density lipoprotein (oxLDL)-induced endothelial cell
ted with oxLDL (130 g/mL) in the absence (middle)
lls stained with 4=,6-diamidino-2-phenylindole.Middle,
ediated deoxy uridine triphosphate nick-end labeling
with flow cytometry. Data are expressed as the mean 
DL treatment.LDL
      o
zed lo
ncuba
p,Ce
se-m
suredtion could be mainly through the ROS scavenger.
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 4 Kuo et al 859NO has pivotal importance in the regulation of vasodi-
lation, leukocyte adhesion, platelet aggregation, and insu-
lin sensitivity. Suppression of NO generation and bioavail-
ability is involved in the development and progression of
atherosclerosis as well as the metabolic syndrome.29 Acti-
vated endothelial cells in atheroma can over-express adhe-
sion molecules, which contribute to monocyte recruit-
ment.30 In many vascular pathologies, a combination of
altered rates of NO production along with an increased
removal of NO leads to an apparent reduction in the
bioavailability of NO. The antithrombotic and antiathero-
sclerotic properties of NO are achieved by its ability to
inhibit the expression of cell surface adhesion molecules
P-selectin, VCAM, and ICAM, and prevent the expression
of MCP-1 and inhibit platelet adhesion under flow condi-
tions.31
We found that pretreatment with SLE significantly
reverses the suppression of eNOS expression by oxLDL,
which had an inhibitory effect on the oxLDL-induced
adhesiveness between monocytes and HVUECs (Fig 4, A
and B), by a mechanism that is possibly linked to a reduc-
tion of cellular superoxide. We next examined the inhibi-
tory effects of SLE on the oxLDL-induced surface expres-
sion of adhesion molecules in HUVECs and found that
SLE repressed the oxLDL-induced surface expression of
these adhesion molecules (Fig 4, C). Further work will be
necessary to fully define the mechanism of SLE-induced
suppression of ROS release from endothelial cells, espe-
cially under conditions of treatment with oxLDL.
There is increasing interest in the application of tradi-
tional Chinese medicines for the prevention and treatment
of cardiovascular disease.32 One of the reasons is because
many phytochemical compounds contained in herbs are
potent antioxidants. OxLDL induces the mobilization of
Ca2.33 Oxygen-derived free radicals and the alteration of
intracellular Ca2 ion homeostasis are now considered
major contributing factors to atherosclerotic coronary ar-
tery disease. ROS increase vascular [Ca2]i by stimulating
inositol trisphosphate-mediated Ca2 mobilization, by in-
creasing cytosolic Ca2 accumulation through sarcoplas-
mic and endoplasmic reticulum Ca2-adenosine triphos-
phatase (ATPase) inhibition, and by stimulating Ca2
influx through Ca2 channels.20
Previous studies demonstrated that calcium channel
blockers inhibited experimental atherosclerosis in cholesterol-
fed animals,34 improved endothelial cell functions by up-
regulating the NO system,35 down-regulated the endothe-
lial receptor for ox-LDL (LOX-1), and inhibited the
CPP32-like protease activity.36 Antioxidants also prevent
both oxLDL-induced ROS generation and Ca2 eleva-
tion.37 ROS such as hydrogen peroxide have been shown
to initiate a Ca2 overload in endothelial cells.38 ROS
generation may inhibit Ca2-ATPases, leading to sustained
elevations of [Ca2]i, which are associated with mitochon-
drial dysfunction through loss of membrane potential and
release of cytochrome c. Our findings indicate that the
antiapoptotic effects of SLE are due to its inhibition of
ROS generation, which in turn represses the release ofendothelial [Ca2]i and stabilizes the mitochondrial
membrane. This then prevents the release of cytochrome
c, a molecule required for the activation of caspase-3.
CONCLUSIONS
SLE is a complex extract. Its chemical ingredients
include aspidistrin, methylproto-aspidistrin, furostanol
glycosides, and steroidal glycosides. To collect sufficient
quantities for extensive use as drug remedies, a precursor-
feeding strategy to enhance the biosynthesis of pharmaceu-
tical sterols by a cell culture of Solanum lyratum has been
developed by Lee et al.39 The present work provides insight
into some of the mechanisms in endothelial cells that
underlie the vascular protective properties of SLE, high-
lighting its effects on the reduction of cellular ROS caused
by oxLDL. Therefore, SLE may be useful for the preven-
tion of the atherosclerotic process. Our study shows that
multiple substances in SLE seem to contribute to its effects.
Further investigations on isolation and characterization of
the active compounds responsible for the antioxidant ca-
pacity of SLE are under way in our laboratory. Our work
adds SLE to the growing list of herbal remedies whose
mode of action has been at least partially revealed on a
molecular level.
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